Background
Private retail drug shops play a significant role in health service delivery in low and middle income countries. Drug shops are small ‘walk-in’ health care shops that sell over-the-counter drugs. Sometimes drug shops sell other products other than medicines. A number of studies have indicated that in many low and middle income countries, retail drug shops are critical in providing health care services, and more so for common childhood illnesses [
1]. In Togo for example, only less than 20% of under-five sick children visit the health facility, and up to 83% are managed at home using medicines procured from the retail market [
2]. In Nigeria, more than 60% of malaria patients obtained their medication through patent medicine vendors (PMVs) – an equivalent of drug sellers [
3,
4]. In Uganda and Tanzania, a sizeable amount of antimalarials are accessed through the retail sector market [
5,
6]. Between 40 and 70% of pediatric fevers in Uganda are managed at retail drug shops, especially in rural areas. Retail drug shops are utilized as first points of call for health care for sick children especially in rural and geographically constrained communities [
7‐
9]. The evidence on the extent of utilization of private retail sector by different socioeconomic groups is mixed, and largely context driven. There are reported variations in utilization of retail drug shops across and within countries. However, in urban areas, private retail sector services were more likely to be utilized by higher socioeconomic groups, compared to rural locations, where the private retail sector is commonly used by the lower socioeconomic groups [
10].
The prominence of retail drug shops owes itself to existing constraints in access to public health services, including: long distances, household poverty, and limited or even lack of well-functioning public health facilities in some geographical areas – characterized by inadequate health workers, drug stock outs, and perceived poor quality services [
6,
9,
11‐
16]. Retail drug shops are perceived to be accessible, convenient, flexible in terms of operating hours, offer credit facilities, trusted by communities, and are perceived to provide services at lower costs [
15,
17‐
19]. However, there are also concerns about the quality of services retail drug shops provide. For example, there are reports that most drug shop attendants are unqualified and lack adequate knowledge and capacity to appropriately identify illnesses and offer appropriate treatment for illnesses, stocking and dispensing substandard, counterfeit, or even expired drugs, among others [
1,
9,
20].
Notwithstanding the reported challenges, retail drug shops are a potential way to increase coverage of health services and achieve universal health coverage (UHC). Retail providers could relieve pressure off a health care system that is struggling to deliver comprehensive health services amidst resource challenges. The Global Fund’s Affordable Medicines Facility Malaria (AMFm) conducted pilot program in eight countries, including Uganda, to test the feasibility of subsidizing medicines through the private sector on availability, affordability and access to medicines. Results from this AMFm pilot, indicated that, indeed, subsidizing medicines provided through the private sector can improve availability, affordability, and access, to medicines particularly for childhood conditions [
21].
In Uganda, drug shops are recognized within the health care system as part of the private for profit (PFP) sector. Retail drug shops are registered, licensed and regulated by the national drug authority (NDA). Drug shops are classified as ‘C’ (permitted to sell a restricted list of medicines, including some antimicrobial formulations). Although drug shops are expected to be registered and licensed before they start operations [
22], this sometimes is not the case. In addition, while the NDA Act stipulates the type of cadre supposed to run the drug shops, often times, there is lack of consistent enforcement and compliance. Sometimes drug shops to present qualified personnel when seeking for accreditation and thereafter recruit unqualified ones once licensure processes are complete. It is therefore not uncommon to find untrained staff working in drug shops in addition to stocking medicines that are not recommended for those classes or drug shops.
While retail drug shops have proliferated in the recent past especially in low and middle income countries, not much attention has been paid to them [
23]. In Uganda, studies have focused more on understanding the role of retail drug shops, quality of services provided, feasibility of using rapid diagnostics at drug shops, delivering family planning products through drug shops, among others [
9,
24‐
28]. However, in Uganda, there is limited information on the structure and operational characteristics of the retail drug shop market. Yet, this would provide an important starting point for designing feasible interventions aimed at improving the potential of retail drug shops to provide appropriate and quality services. The aim of this paper was to characterize private retail drug shops, their operational environment, as well as elicit factors that influence their day-to-day decisions in the management of febrile conditions among children less than five years old in rural South Western Uganda.
Discussion
In this study, we sought to characterize the private retail drug shops, explore their operational environment, as well as elicit factors that influence their day-to-day decisions in the management of febrile conditions among children less than five years old in rural South Western Uganda. Although the study focused on one segment of the retail health market – the registered retail drug shops – the results presented have indeed revealed interesting features of the retail drug shops, which are significant for policy and programming. The main findings indicate that most surveyed retail drug shop premises met the NDA requirements of setting up premises that deal in medicines. These guidelines were established to assure medicines safety and quality. Drug sellers had health-related qualification with majority being nurses or midwifes. The most commonly reported and managed childhood illness signs and symptoms at drug shops were fever, cough, rapid or difficult breathing, and diarrhea. It was also found that retail drug shops commonly stocked Paracetamol, Quinine, Cough syrup, ORS/Zinc, Amoxicillin dry syrup, Septrin® syrup, Artemisinin-based Combination Therapies, and multivitamins. Decisions on what medicines to stock were influenced by among others, Ministry of Health recommended medicines, medicines demand, most profitable medicines, and seasonal disease patterns. Relatedly, dispensing decisions were influenced by among others: prescriptions presented by the client, patients’ finances, and patient preferences. In response to clients with insufficient resources, drug sellers either offered credit depending on the relationship and trust cultivated overtime, or offered cheaper product alternatives.
Our finding that most of drug sellers (attendants) had health related qualifications – with the common qualification being nurses or midwifes, and clinicians, could be related to the fact that only registered drug shops were enrolled for the survey, owing to the legal and policy challenges that would arise by engaging un-registered and hence unauthorized entities. It is not uncommon during registration and licensure to ensure drug sellers with appropriate qualification are responsible, otherwise a license may never be granted. It is relatively complex to enforce such requirements for unregistered drug shops that are essentially operating illegally. It is important however to note that while the new NDA Professional Licensing guidelines 2018 [
33] allow nurses, midwives, and Pharmacy Technicians or dispensers to attend to human drug shops, within the context of Uganda’s medical training system, nurses and midwives had no special training that would aid them to prescribe medicines. For long, it had been Pharmacy Technicians who were allowed these roles, but with the current health workforce challenges that characterize Uganda, manifesting in chronic shortages for human resources for health, this may not be possible. The training and skills of drug sellers or attendants has a significant bearing on the quality of services offered at retail drug shops. Mbonye and colleagues, found professional qualification of a provider to be highly associated prescriptive practice, with lower cadre staff (nursing assistants and enrolled nurses) overprescribed antibiotic [
34]. There are other studies that have reported gaps on training and skills of drug sellers [
35,
36] However, with minimal complementary training and capacity building support for example through continuous training, monitoring and onsite support supervision, drug sellers could improve their treatment and dispensing practices and hence improve quality of care provided [
9,
37,
38].
Our study found that most drug shop premises met the NDA requirements allowed for premises that operate drug shops. We found that most surveyed drug shops had secure drug storage, medicines were protected against moisture and sunlight, and drug shops operated under controlled room temperature. Appropriate conditions for storage and dispensing of medicines are critical in maintaining their quality and safety during their shelf life. We found that some drug shops provided additional services and products beyond medicines, including soft drinks, mobile phone credit, deworming, and immunization services. For the few drug shops that provided immunization services, additional storage capacities for vaccines (e.g. refrigeration and cold chain systems) were not available yet extremely necessary. However, it is important to note that the current NDA guidelines and policy framework does not allow retail drug shops to provide such services. Business diversification, the drug sellers argued, was a mechanism for business sustainability and mitigating high operational costs. The more diversified the business, the less likely that a drug shop would rely on one business line as source of business survival. Product and service diversification increases retail sales volumes and significantly reduces the average costs of production, with possibilities of transferring these cost cuttings to clients in form of reduced prices [
39]. Aspects of incentives for business start-ups and operational costs in retail health markets, was investigated separately by the author and colleagues, and findings shall be shared in separate publication. It is important, however, that these additional lines of business are related to the mainstream service or products being offered. Drug shop operators must also balance this diversification agenda against its feasibility, risks, and limitations.
The most common childhood illnesses reported at the drug shops were found to be fevers, coughs, difficulty in breathing, and diarrhea. The current burden of childhood illnesses in Uganda, shows that malaria, acute respiratory illness and diarrhea are major contributors to mortality and morbidity for children under five years of age [
29], and this is true for Sub-Saharan Africa (SSA). To achieve greater reductions in the burden of under-five mortality and improve child survival in Uganda, retail drug shops must be brought into perspective. Retail drug shop practices need to be improved. In this study, we found limited use of diagnostics – malaria RDTs, respiratory count timers, and thermometers. As starting point, there is need to improve diagnostic capacities of retail drug shops as a critical ingredient for appropriate treatment and care, and well in line with the current WHO “test and treat” policy [
26,
40,
41].
The potential for drug shops to use RDTs and reduce the unnecessary prescription and use of antimalarials has been demonstrated by a number of studies conducted in many settings, including in Uganda [
26,
42] [
27,
28,
43]. The WHO “
test before treat policy” now recommends parasitological confirmation of malaria before antimalarials are provided [
44]. Indeed, the WHO Framework on malaria elimination under the Global Technical Strategy for Malaria 2016–2030, provides for creating an enabling environment for ensuring universal access to malaria prevention, diagnosis, and treatment [
45]. Inappropriate treatment resulting from the limited application of diagnostics has been a consistent finding across a number of studies [
46‐
49]. Inappropriate prescription and unnecessary use of antibiotics has been established to be associated with antimicrobial resistance (AMR) [
50], which is currently a global public health challenge that must be addressed. The current Malaria Treatment Policy and the Uganda Malaria Control strategic Plan now recommend the use of RDTs at community level and in the private sector [
51], and additional guidelines for using RDTs in private outlets in Uganda have been developed [
52] . The Global Fund for HIV/AIDS, Malaria, and Tuberculosis (GFMAT) through the private sector co-funding mechanism, has also been supporting the private sector in improving the standards of malaria diagnosis and treatment in Uganda. However, there are important challenges such as training and supervision, waste management, streamlining the referral system from private outlets, surveillance, etc. that need to be considered [
53]. The policy reforms being undertaken require careful planning and consideration of training, regulatory, supervisory, and other necessary capacities, coupled with necessary incentives for private outlets to improve their practices [
26].
Our study found that prescription or dispensing decisions were not only related to existing diagnostic capacities, but were also influenced by other factors, including: the clients’ finances, prescriptions that patients came with, and client’s preferences. Wafula and colleagues, in a systematic review of drug shops in Sub-Saharan Africa, reported that, among others, client demand strongly influenced dispensing practices. They noted that most drug shops simply sold medicines that clients requested for or preferred, without necessarily following policy recommendations. The systematic review also reported that, rural drug shops provided credit facilities to their clients, in cases where they had no resources to afford the full dosages of medicines [
54]. Similarly, Goel and colleagues, in their study of the behavior of retail pharmacies in developing countries, also reported that client demand or expectations as well as local regulatory factors strongly influenced drug selection and dispensing behavior [
55]. Evidence from both our study and the literature, indicate that dispensing behavior is related to both demand and supply side factors, and thus, improving dispensing practices requires strategies or interventions on both the demand side and supply side of the market. For example, training, monitoring, supervision, and subsidies (supply side) are critical supply-side strategies. They alone, may not be sufficient in influencing dispensing behavior, rather, additional demand-side initiatives are necessary. Programs such as public health education and the provision of adequate information through mass media campaigns, may address issues of adverse effects of incomplete dosages, and the dangers of self-medication and prescription. Other demand-side strategies may include social marketing and the provision of demand-side subsidies. Demand-side strategies are aimed at influencing consumer behavior, preferences, and choices, and this would ultimately influence dispensing practice [
54]. The design of any package of interventions and market incentives, must however recognize the broader health system effects that may likely emerge from those interventions, beyond the market where they are implemented [
19].
Relatedly, drug shop attendants indicated that their medicine stocking decisions were influenced by: medicines on demand, ministry of health recommended, most profitable medicines, and seasonal dynamics. These factors have also been identified in studies elsewhere [
56‐
58]. According to the NDA Act, drug shops are not expected to store and dispense antibiotics, except in exceptional circumstances where a drug shop is allowed to sell antibiotics especially if the drug shop is the only sources of such life-saving medicines for particular communities [
22]. Our study however, found that amoxicillin (syrup and capsules) was one of the commonly stocked and dispensed medicines at surveyed drug shops because of its high demand. In many cases, drug shops that stored antibiotics did not display them on the shelf for fear of reprisals from drug inspectors, but would provide the client the same on demand. In addition, drug shops were still found with stocks of medicines such as quinine that are no longer recommended as first-line treatment for malaria. Surprisingly, the study found that most drug shops had clinical guidelines and regulations available, yet it was clear that many drug sellers were not in many cases adhering to them. It was not apparently clear whether it was a deficiency in enforcement, inadequacy in training, or rather an issue of incentives for adherence. Reflecting on elicited factors that influence treatment practices, private retail drug shops were likely to promote the practice of self-medication, especially in circumstances where client preferences, and prescriptions that come with, were major considerations in dispensing decisions. Incentive mechanisms that enable drug shops to adhere to rules could be established, including strong monitoring and supervision and deregistration in cases of inappropriate practices [
59,
60].
Finally, this study profiled the drug shop clients socioeconomically to get a basic understanding of the type of clients who procure medicines from the retail drug shops and the related equity issues. This study found that care-seekers of children under five years of age who sought care from retail drug shops during the survey period were mostly those who are unemployed, self-employed and less educated. In Uganda, it is not uncommon to find strong relationships between these strata and lower socioeconomic quintiles. It is important to note that the poor are also the most vulnerable to the burden of ill-health. Thus, interventions aimed at improving retail drug shop practices were likely to benefit the poor in society and ensure improved equity in access to health care. However to achieve higher equity, a mix of interventions, including consumer economic empowerment, and a stronger regulatory regime could cushion consumers against possible market distortions and exploitation in the form of high prices and poor quality of products and services. In addition, there is need to establish the right incentives that will influence provider and consumer behavior towards outcomes that are in public interest [
19] [
61,
62].
This study however, had some limitations that need to be underscored, including the fact that only registered retail drug shops were included in the study. Yet, there are many unregistered drug shops that partly influence what happens in that market, and so the results reported can only be relevant to the extent of registered drug shops. Unlicensed outlets were excluded from the survey because it would have been ethically unacceptable to promote “outlets” that have selected to defy an existing regulatory regime. Secondly, the determination of appropriate treatment was based on responses from care-seekers during exit interviews. We asked the client what signs and symptoms they had reported to the drug seller, observed the medicines that had been provided, and also compared with clinical guidelines and WHO guidelines on promoting rational use of medicines, to generate an “appropriate treatment” outcome. This may have inherent flaws especially the reliance on signs and symptoms reported without due diagnosis for conclusiveness. We however endeavored to validate the response with the drug seller on reported symptoms of immediate previous client, after the exit interview.